Endometrial cancer drug trial halted early after recruiting only 12 patients
NCT ID NCT05454358
First seen Jan 11, 2026 · Last updated Jun 16, 2026 · Updated 24 times
Summary
This study aimed to see if taking the drug letrozole after standard treatment could help prevent endometrial cancer from coming back. It was designed for patients whose cancer did not have a specific genetic profile. However, the trial was stopped early and only enrolled 12 people, so no strong conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.